Brainsway (BWAY) Change in Working Capital (2018 - 2026)
Brainsway (BWAY) posted quarterly Change in Working Capital of -$1.8 million for Q1 2026, down 165.4% year-on-year from $2.7 million in Q1 2025, and up 57.62% on a QoQ basis from -$4.1 million in Q4 2025.
Brainsway (BWAY) Change in Working Capital (2018 - 2026) Analysis & Trends
Brainsway (BWAY) has reported Change in Working Capital for 9 consecutive years, with -$1.8 million the latest figure, recorded in Q1 2026.
- Quarterly Change in Working Capital fell 165.4% year-over-year to -$1.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.1 million (down 15.8% YoY) and the FY2025 annual result came in at $8.2 million, up 241.89% from the prior year.
- Change in Working Capital grew to -$1.8 million in Q1 2026 per BWAY's latest filing, from -$4.1 million in the prior quarter.
- Over the last five years, Change in Working Capital for BWAY reached as high as $11.0 million in Q2 2025 and fell as low as -$4.1 million in Q4 2025.
- A 5-year average of $496176.5 and a median of $135000.0 in 2023 frame the typical range for Change in Working Capital.
- The largest YoY upside for Change in Working Capital was 99818.18% in 2025 against a maximum downside of 6806.9% in 2025.
- Year by year, Change in Working Capital stood at $682000.0 in 2022, then jumped by 81.38% to $1.2 million in 2023, then fell by 19.08% to $1.0 million in 2024, then plunged by 514.39% to -$4.1 million in 2025, then jumped by 57.62% to -$1.8 million in 2026.
- According to Business Quant data, Change in Working Capital over the past three periods registered -$1.8 million, -$4.1 million, and -$1.9 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Working Capital (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | - |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | - |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -128.78 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | Brainsway | 646.63 Mn | 587.74 Mn | 11.68 Mn | -1.76 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.76 Mn |
| Mar 31, 2026 | -1.76 Mn |
| Dec 31, 2025 | -4.15 Mn |
| Dec 31, 2025 | -4.15 Mn |
| Sep 30, 2025 | -1.95 Mn |
| Sep 30, 2025 | -1.95 Mn |
| Jun 30, 2025 | 10.99 Mn |
| Jun 30, 2025 | 10.99 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Mar 31, 2025 | 2.69 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Dec 31, 2024 | 1.00 Mn |
| Sep 30, 2024 | 29,000.00 |
| Sep 30, 2024 | 29,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Jun 30, 2024 | 11,000.00 |
| Mar 31, 2024 | 1.35 Mn |
| Mar 31, 2024 | 1.35 Mn |
| Dec 31, 2023 | 1.24 Mn |
| Dec 31, 2023 | 1.24 Mn |